title: Treatment of acute myocardial infarction today.
abstract: The management of acute myocardial infarction (AMI) has undergone major changes in the last decade. Today clinical practice can be based on sound evidence derived from a large number of well-conducted, randomized, large-scale clinical trials. Because of this, Scientific Societies, such as the European Society of Cardiology, have recently produced evidence-based guidelines for the treatment of AMI. This article summarizes the up-to-date, evidence-based treatments for patients with AMI, and their limitations in terms of uncertainty and transferability to real populations.
authors.affiliation: Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche M. Negri, Milan, Italy.
authors.forename: A P
authors.initials: AP
authors.lastname: Maggioni
authors.forename: F
authors.initials: F
authors.lastname: Sessa
authors.forename: R
authors.initials: R
authors.lastname: Latini
authors.forename: G
authors.initials: G
authors.lastname: Tognoni
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D015906:Angioplasty, Balloon, Coronary; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000628:therapy; D015912:Thrombolytic Therapy
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001241:Aspirin